22 May 2013
Keywords: morphosys, gets, first, ab, milestone, novartis, german
Article | 15 August 2005
German company MorphoSys AG has finished its first therapeutic antibody program undertaken together with Swiss drug major Novartis.
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
15 August 2005
8 August 2005
21 May 2013
© 2013 thepharmaletter.com